CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-02 | OYLER JOHN Chief Executive Officer | Sale | −49,092 | $41.25 | $2.0M | 273,385 |
| 2017-02-27 | Wang Xiaodong Director | Sale | −4,444 | $38.10 | $169K | 161,649 |
| 2017-02-24 | Wang Xiaodong Director | Sale | −27,902 | $38.13 | $1.1M | 166,593 |
| 2017-02-24 | Wang Xiaodong Director | Sale | −500 | $38.54 | $19K | 166,093 |
| 2017-02-23 | Wang Xiaodong Director | Sale | −5,505 | $38.57 | $212K | 194,495 |
| 2017-02-21 | OYLER JOHN Chief Executive Officer | Sale | −7,426 | $39.83 | $296K | 325,410 |
| 2017-02-21 | OYLER JOHN Chief Executive Officer | Sale | −2,933 | $40.36 | $118K | 322,477 |
| 2017-02-17 | OYLER JOHN Chief Executive Officer | Sale | −7,204 | $40.67 | $293K | 332,836 |
| 2017-02-16 | OYLER JOHN Chief Executive Officer | Sale | −9,057 | $40.23 | $364K | 378,383 |
| 2017-02-16 | OYLER JOHN Chief Executive Officer | Sale | −38,343 | $40.75 | $1.6M | 340,040 |
| 2016-11-23 | Wang Xiaodong Director | Sale | −93,750 | $32.00 | $3.0M | 0 |
| 2016-11-23 | Malley Thomas Director | Purchase | +30,000 | $32.00 | $960K | 30,000 |
| 2016-11-18 | BAKER BROS. ADVISORS LP Director | Purchase | +165,824 | $32.00 | $5.3M | 355,198 |
| 2016-11-18 | BAKER BROS. ADVISORS LP Director | Purchase | +1,594,671 | $32.00 | $51.0M | 3,317,977 |
| 2016-11-16 | OYLER JOHN Chief Executive Officer | Grant or award · Share Option (Right to buy) | +2,047,500 | 2,047,500 | ||
| 2016-11-16 | Liang Howard CFO & CSO | Grant or award · Share Option (Right to Buy) | +1,752,500 | 1,752,500 | ||
| 2016-11-16 | Wang Xiaodong Director | Grant or award · Share Option (Right to Buy) | +1,613,430 | 1,613,430 | ||
| 2016-09-28 | Glazer Donald W. Director | Sale | −30,163 | $30.47 | $919K | 11,300 |
| 2016-09-28 | Glazer Donald W. Director | Sale | −11,300 | $31.16 | $352K | 0 |
| 2016-09-27 | Glazer Donald W. Director | Sale | −26,483 | $29.63 | $785K | 41,463 |
Page 120 of 123 · 2,455 trades